Induction of the chemokine β peptides, MIP-1α and MIP-1β, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γ-IFN, IL-10, IL-4, and TGF-β

Molecular Medicine

Volumn 4, Issue 10, 1998, Pages 648-657

  Sherry, Barbara ^a   Espinoza, Marisol ^a   Manogue, Kirk R ^a   Cerami, Anthony ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0031760345     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401925     Document Type: Article

References (24)

1. Adams DO, Hamilton TA. (1992) Molecular basis of macrophage activation: diversity and its origin. In Lewis CE, McGhee JOD (eds). The Natural Immune System Volume II: The Macrophage. Oxford University Press, Oxford, pp. 75-79.
2. Nathan CF. (1987) Secretory products of macrophages. J. Clin. Invest. 79: 319-326.
3. Wolpe SD, Cerami A. (1989) Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3: 2565-2573.
4. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. (1991) Properties of the novel proinflammatory superfamily "intercrine" cytokine family. Annu. Rev. Immunol. 9: 617-648.
5. Lindley JD, Westwick J, Kunkel SL. (1993) Nomenclature announcement - the chemokines. Immunol. Today 14: 24.
6. Baggiolini M, Dewald B, Moser B. (1994) IL-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55: 97-179.
7. Miller MD, Krangel MS. (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. CRC Crit. Rev. Immunol. 12: 17-46.
8. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. (1993) Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 260: 355-358.
9. Schall TJ, Bacon K, Camp RDR, Kaspari JW, Goeddel DV. (1993) Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177: 1821-1825.
10. Fahey TJ III, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B. (1992) Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148: 2764-2769.
11. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A. (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 117: 570-581.
12. Luedke CE, Cerami A. (1990) Interferon-γ overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J. Clin. Invest. 86: 1234-1240.
13. Mosmann R. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
14. Green LM, Reade JL, Ware CF. (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Methods 70: 257-268.
15. Chantry D, Turner M, Abney E, Feldmann M. (1989) Modulation of cytokine production by transforming growth factor-β. J. Immunol. 142: 4295-4300.
16. Ohmori Y, Hamilton TA. (1994) IFN-γ selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/ melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J. Immunol. 153: 2204-2212.
17. Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL. (1992) Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149: 1470-1475.
18. Tsicopoulos A, Hamid Q, Varney V, Ying S, Moqbel R, Durham SR, Kay AB. (1992) Preferential messenger mRNA expression of Th1-type cells (IFN-γ, IL-2) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol. 148: 2058-2061.
19. Hart PH, Vitti GF, Burgess GR, Whitty GA, Piccoli DS, Hamilton JA. (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. U.S.A. 86: 3803-3807.
20. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142: 3857-3861.
21. Standiford TJ, Kunkel SL, Liebler JM, Burdick MD, Gilbert AR, Stricter RM. (1993) Gene expression of macrophage inflammatory protein-1α from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell. Mol. Biol. 9: 192-198.
22. Sporn MB, Roberts AB. (1992) Transforming growth factor-β: recent progress and new challenges. J. Cell Biol. 119: 1017-1021.
23. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. (1993) Transforming growth factor-1β null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90: 770-774.
24. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzed G, Calvin D, Annunziaata N, Doetschman T. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.